Free Trial

EOM Pharmaceuticals (IMUC) Short Interest Ratio & Short Volume

EOM Pharmaceuticals logo
$0.11 0.00 (0.00%)
As of 05/23/2025

EOM Pharmaceuticals Short Interest Data

EOM Pharmaceuticals (IMUC) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 8,172 shares to cover all short positions.

Current Short Interest
100 shares
Previous Short Interest
100 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$12.40
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
126,503,000 shares
Percentage of Shares Shorted
0.00%
Today's Trading Volume
0 shares
Average Trading Volume
8,172 shares
Today's Volume Vs. Average
0%
Short Selling EOM Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for EOM Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IMUC Short Interest Over Time

IMUC Days to Cover Over Time

IMUC Percentage of Float Shorted Over Time

EOM Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2025100 shares $12.40 No ChangeN/A0 $0.12
4/15/2025100 shares $13.88 No Change0.0%0.1 $0.14
3/31/2025100 shares $15.45 No Change0.0%0 $0.15
3/15/2025100 shares $15.50 No Change0.0%0 $0.16
2/28/2025100 shares $16.00 No Change0.0%0 $0.16
2/15/2025100 shares $15.79 No Change0.0%0 $0.16
1/31/2025100 shares $16.00 No ChangeN/A0 $0.16
1/15/2025100 shares $15.99 No ChangeN/A0 $0.16
12/31/2024100 shares $16.88 No ChangeN/A0 $0.17
12/15/2024100 shares $17.80 No ChangeN/A0 $0.18
11/30/2024100 shares $17.00 No ChangeN/A0 $0.17
11/15/2024100 shares $13.40 No ChangeN/A0 $0.13
10/31/2024100 shares $13.80 No ChangeN/A0.1 $0.14
10/15/2024100 shares $11.70 -50.0%N/A0 $0.12
9/30/2024200 shares $23.40 -50.0%N/A0.1 $0.12
9/15/2024400 shares $55.20 No ChangeN/A0.3 $0.14
8/31/2024400 shares $67.60 No ChangeN/A0.1 $0.17
8/15/2024400 shares $48.00 -33.3%N/A0.1 $0.12
7/31/2024600 shares $92.94 -14.3%N/A0.2 $0.15
7/15/2024700 shares $118.30 No ChangeN/A0.9 $0.17
6/30/2024700 shares $120.89 +600.0%N/A0.1 $0.17
6/15/2024100 shares $19.00 No ChangeN/A0.1 $0.19
5/31/2024100 shares $19.90 No ChangeN/A0 $0.20
5/15/2024100 shares $21.00 No ChangeN/A0 $0.21
4/30/2024100 shares $19.79 -75.0%N/A0.1 $0.20
4/15/2024400 shares $56.84 +300.0%N/A0.1 $0.14
3/31/2024100 shares $15.20 No ChangeN/A0 $0.15
3/15/2024100 shares $25.59 No ChangeN/A0 $0.26
2/29/2024100 shares $29.29 No ChangeN/A0 $0.29
2/15/2024100 shares $29.00 No ChangeN/A0.1 $0.29
1/15/2024100 shares $39.78 No ChangeN/A0 $0.40
12/31/2023100 shares $23.20 No ChangeN/A0 $0.23
12/15/2023100 shares $22.11 -75.0%N/A0 $0.22
11/30/2023400 shares $74.00 No ChangeN/A0.5 $0.19
11/15/2023400 shares $132.00 -86.2%N/A0 $0.33
10/31/20232,900 shares $638.00 +81.3%N/A2.2 $0.22
10/15/20231,600 shares $430.24 No ChangeN/A0.6 $0.27
9/30/20231,600 shares $272.00 +433.3%N/A0.4 $0.17
9/15/2023300 shares $81.00 +200.0%N/A0 $0.27
8/31/2023100 shares $20.00 No ChangeN/A0 $0.20
Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad)

A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.

Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks.
8/15/2023100 shares $25.01 No ChangeN/A0 $0.25
7/31/2023100 shares $37.79 No ChangeN/A0 $0.38
7/15/2023100 shares $39.99 No ChangeN/A0.1 $0.40
6/30/2023100 shares $38.00 No ChangeN/A0.1 $0.38
6/15/2023100 shares $28.80 No ChangeN/A0 $0.29
5/31/2023100 shares $23.74 No ChangeN/A0.1 $0.24
5/15/2023100 shares $35.00 No ChangeN/A0 $0.35
4/30/2023100 shares $26.00 No ChangeN/A0 $0.26
4/15/2023100 shares $34.99 No ChangeN/A0 $0.35
3/31/2023100 shares $28.00 -83.3%N/A0 $0.28
3/15/2023600 shares $336.00 +20.0%N/A0.2 $0.56
2/28/2023500 shares $239.40 -37.5%N/A0.2 $0.48
2/15/2023800 shares $462.32 -57.9%N/A0.4 $0.58
1/31/20231,900 shares $1,178.00 +1,800.0%N/A0.5 $0.62
1/15/2023100 shares $50.55 No ChangeN/A0 $0.51
12/30/2022100 shares $81.97 -50.0%N/A0 $0.82
12/15/2022200 shares $158.00 -96.4%N/A0 $0.79
11/30/20225,500 shares $5,170.00 -3.5%N/A1.1 $0.94
11/15/20225,700 shares $4,902.00 No ChangeN/A0.6 $0.86
10/31/20225,700 shares $5,014.86 -3.4%N/A1.1 $0.88
10/15/20225,900 shares $4,307.00 -6.4%N/A1.2 $0.73
9/30/20226,300 shares $5,292.00 +1,160.0%N/A0.7 $0.84
9/15/2022500 shares $304.95 -61.5%N/A0 $0.61
8/31/20221,300 shares $753.87 +160.0%N/A0.3 $0.58
8/15/2022500 shares $295.00 +400.0%N/A0.1 $0.59
7/31/2022100 shares $60.00 -97.4%N/A0 $0.60
7/15/20223,900 shares $1,013.61 +333.3%N/A0.4 $0.26
6/30/2022900 shares $225.00 -10.0%N/A0.1 $0.25
6/15/20221,000 shares $280.30 -33.3%N/A0.2 $0.28
5/31/20221,500 shares $419.85 -6.3%N/A0.3 $0.28
5/15/20221,600 shares $480.00 +700.0%N/A0.1 $0.30
4/30/2022200 shares $74.00 -50.0%N/A0 $0.37
4/15/2022400 shares $93.80 +300.0%N/A0.1 $0.23
3/31/2022100 shares $23.48 No ChangeN/A0 $0.23
3/15/2022100 shares $23.50 No ChangeN/A0 $0.24
2/28/2022100 shares $24.00 No ChangeN/A0 $0.24
2/15/2022100 shares $21.60 No ChangeN/A0 $0.22
1/31/2022100 shares $23.99 No ChangeN/A0 $0.24
1/15/2022100 shares $20.00 -75.0%N/A0 $0.20
12/31/2021400 shares $168.00 +300.0%N/A0 $0.42
12/15/2021100 shares $51.00 No ChangeN/A0 $0.51
11/30/2021100 shares $64.00 No ChangeN/A0 $0.64
11/15/2021100 shares $64.90 No ChangeN/A0 $0.65
10/29/2021100 shares $67.00 -90.9%N/A0 $0.67
10/15/20211,100 shares $649.00 -42.1%N/A0 $0.59
9/30/20211,900 shares $1,102.00 +1,800.0%N/A0.2 $0.58
9/15/2021100 shares $50.00 No ChangeN/A0 $0.50
8/31/2021100 shares $38.01 -94.1%N/A0 $0.38
8/13/20211,700 shares $972.23 -19.1%N/A0.3 $0.57
7/30/20212,100 shares $987.00 +110.0%N/A0.3 $0.47
$19 for a FULL YEAR of stock picks?! (Ad)

Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.

Watch the exclusive AI investor briefing >>>
7/15/20211,000 shares $450.00 -65.5%N/A0.1 $0.45
6/30/20212,900 shares $1,885.00 +2,800.0%N/A0.2 $0.65
6/15/2021100 shares $61.00 -80.0%N/A0 $0.61
5/28/2021500 shares $285.00 -72.2%N/A0 $0.57
5/14/20211,800 shares $899.64 +157.1%N/A0.4 $0.50
4/30/2021700 shares $343.00 +600.0%N/A0.2 $0.49
4/15/2021100 shares $51.00 -88.9%N/A0 $0.51
3/31/2021900 shares $490.50 No ChangeN/A0.1 $0.55
3/15/2021900 shares $657.00 -77.5%N/A0.1 $0.73
2/26/20214,000 shares $3,392.00 +1,900.0%N/A0.1 $0.85
2/12/2021200 shares $184.00 +100.0%N/A0 $0.92
1/29/2021100 shares $57.50 -99.4%N/A0 $0.58
1/15/2021800 shares $384.00 +700.0%N/A0 $0.48
12/31/20206,100 shares $2,440.00 +662.5%N/A0.2 $0.40
12/15/2020800 shares $223.51 +700.0%N/A0 $0.28
11/30/2020100 shares $25.49 No ChangeN/A0 $0.25
11/15/2020100 shares $26.88 No ChangeN/A0 $0.27
10/30/2020100 shares $29.99 -80.0%N/A0 $0.30
10/15/2020500 shares $175.00 No ChangeN/A0 $0.35
9/15/20201,200 shares $36.00 -73.9%N/A0 $0.03

IMUC Short Interest - Frequently Asked Questions

What is EOM Pharmaceuticals' current short interest?

Short interest is the volume of EOM Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 100 shares of IMUC short. Learn More on EOM Pharmaceuticals' current short interest.

How does EOM Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to EOM Pharmaceuticals: Skye Bioscience, Inc. (18.48%), Outlook Therapeutics, Inc. (17.45%), Repare Therapeutics Inc. (1.65%), Immix Biopharma, Inc. (1.33%), Biomea Fusion, Inc. (30.40%), Gain Therapeutics, Inc. (1.06%), Renovaro Inc. (6.45%), Precision BioSciences, Inc. (22.45%), Ikena Oncology, Inc. (0.93%), Armata Pharmaceuticals, Inc. (0.07%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short EOM Pharmaceuticals stock?

Short selling IMUC is an investing strategy that aims to generate trading profit from EOM Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against EOM Pharmaceuticals?

A short squeeze for EOM Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMUC, which in turn drives the price of the stock up even further.

How often is EOM Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMUC, twice per month. The most recent reporting period available is April, 30 2025.




This page (OTCMKTS:IMUC) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners